QNRX Quoin Pharma Quarterly Revenue Growth

Symbol and logo of brand Quoin Pharmaceuticals Ltd. (QNRX)

Quoin Pharmaceuticals focuses on patents and the treatment of rare skin pathologies, including Netherton syndrome. The company is developing scientific partnerships with specialized funds to create innovative therapies. Its environmental approach is limited to compliance with laboratory standards. The value of 0.00 shows the current figure visualized by the QoQ revenue growth rate on this chart.

QNRX quoinpharma.com Sales Growth QoQ (07/04/2022 - 11/21/2026)

Comprehensive metric breakdowns and analytics for Quoin Pharma (QNRX)

- current quotes and average value forecast:
General company analysis:Quoin Pharmaceuticals Ltd. (QNRX)
Mass-produced product of Quoin Pharmaceuticals Ltd

To filter blue-chip assets, investors utilize revenue dynamics as a marker of operational efficiency and market expectations. The QoQ revenue growth metric measures the percentage change in sales between consecutive quarters, which for Quoin Pharmaceuticals (QNRX), currently in the clinical scaling stage of drugs for rare skin diseases, reflects the pace of commercialization and the success of partnerships with pharma behemoths.